11 Deer Park Drive, Suite 103
United States of America, New Jersey
ExSAR is now a clinical developmental stage company dedicated to identifying, developing and commercializing small-molecule therapeutics for diseases of protein conformation.
As a leader in the application of Hydrogen/Deuterium exchange technology, ExSAR provides H/D-Ex technology services to third parties. In this capacity, ExSAR offers epitope mapping services in support of monoclonal therapeutic antibody development. ExSAR also employs hydrogen/deuterium exchange to characterize proteins, including biogenerics and to identify ligand binding sites, typically in conjunction with fragment based drug discovery programs.